Platelet-Specific PDGFB Ablation Impairs Tumor Vessel Integrity and Promotes Metastasis
2020 · Cancer Research · 113 citations
https://doi.org/10.1158/0008-5472.can-19-3533
A
Anahita Hamidi
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
62
Papers
1.6K
Citations
18
h-index
23
i10-index
Anahita Hamidi is an academic researcher from Amgen (United States). The author has contributed to research in topics: Venous Thromboembolism Diagnosis and Management & Regulation of Appetite and Obesity & Platelet Disorders and Treatments. The author has an h-index of 18, co-authored 53 publications.
ORCID: 0000-0002-5445-2446Papers by this author
worksSUMOylation of PDGF receptor α affects signaling via PLCγ and STAT3, and cell proliferation
2023 · BMC Molecular and Cell Biology · 3 citations
https://doi.org/10.1186/s12860-023-00481-6
LBA101 Tarlatamab as second-line (2L) treatment for small cell lung cancer (SCLC): Outcomes by chemotherapy-free interval (CFI) and prior PD-(L)1 inhibitor use in the phase III DeLLphi-304 trial
2025 · Annals of Oncology · 0 citations
https://doi.org/10.1016/j.annonc.2025.09.118
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat